Intraperitoneal Chemotherapy without Bevacizumab versus Intravenous Chemotherapy with Bevacizumab as the Frontline Adjuvant Therapy in Advanced Ovarian Cancer. - Ting WH; Chen HH; Wei MC; Sun HD; Hsiao SM (Cancers, 2024)